Payments to Acquire Property, Plant, and Equipment of Protalix BioTherapeutics, Inc. from 31 Dec 2010 to 31 Mar 2025

Taxonomy & unit
us-gaap: USD
Description
The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
Summary
Protalix BioTherapeutics, Inc. quarterly and annual Payments to Acquire Property, Plant, and Equipment in USD history and change rate from 31 Dec 2010 to 31 Mar 2025.
  • Protalix BioTherapeutics, Inc. Payments to Acquire Property, Plant, and Equipment for the quarter ending 31 Mar 2025 was $306,000, a 49% decline year-over-year.
  • Protalix BioTherapeutics, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2024 was $1,282,000, a 12% increase from 2023.
  • Protalix BioTherapeutics, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2023 was $1,149,000, a 83% increase from 2022.
  • Protalix BioTherapeutics, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2022 was $628,000, a 57% decline from 2021.
Source SEC data
View on sec.gov
Payments to Acquire Property, Plant, and Equipment, Quarterly (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Quarterly Change (%)
Payments to Acquire Property, Plant, and Equipment, Annual (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Annual Change (%)

Protalix BioTherapeutics, Inc. Quarterly Payments to Acquire Property, Plant, and Equipment (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $306,000 -$292,000 -49% 01 Jan 2025 31 Mar 2025 10-Q 09 May 2025 2025 Q1
Q1 2024 $598,000 +$350,000 +141% 01 Jan 2024 31 Mar 2024 10-Q 09 May 2025 2025 Q1
Q1 2023 $248,000 +$19,000 +8.3% 01 Jan 2023 31 Mar 2023 10-Q 10 May 2024 2024 Q1
Q1 2022 $229,000 -$157,000 -41% 01 Jan 2022 31 Mar 2022 10-Q 04 May 2023 2023 Q1
Q1 2021 $386,000 +$320,000 +485% 01 Jan 2021 31 Mar 2021 10-Q 16 May 2022 2022 Q1
Q1 2020 $66,000 -$104,000 -61% 01 Jan 2020 31 Mar 2020 10-Q 14 May 2021 2021 Q1
Q1 2019 $170,000 -$79,000 -32% 01 Jan 2019 31 Mar 2019 10-Q 01 Jun 2020 2020 Q1
Q1 2018 $249,000 +$29,000 +13% 01 Jan 2018 31 Mar 2018 10-Q 06 May 2019 2019 Q1
Q1 2017 $220,000 -$31,000 -12% 01 Jan 2017 31 Mar 2017 10-Q 18 Mar 2019 2018 Q1
Q1 2016 $251,000 +$152,000 +154% 01 Jan 2016 31 Mar 2016 10-Q 10 May 2017 2017 Q1
Q1 2015 $99,000 -$164,000 -62% 01 Jan 2015 31 Mar 2015 10-Q 09 May 2016 2016 Q1
Q1 2014 $263,000 -$379,000 -59% 01 Jan 2014 31 Mar 2014 10-Q 07 May 2015 2015 Q1
Q1 2013 $642,000 -$168,000 -21% 01 Jan 2013 31 Mar 2013 10-Q 08 May 2014 2014 Q1
Q1 2012 $810,000 -$1,794,000 -69% 01 Jan 2012 31 Mar 2012 10-Q 09 May 2013 2013 Q1
Q1 2011 $2,604,000 01 Jan 2011 31 Mar 2011 10-Q 09 May 2012 2012 Q1

Protalix BioTherapeutics, Inc. Annual Payments to Acquire Property, Plant, and Equipment (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $1,282,000 +$133,000 +12% 01 Jan 2024 31 Dec 2024 10-K 17 Mar 2025 2024 FY
2023 $1,149,000 +$521,000 +83% 01 Jan 2023 31 Dec 2023 10-K 17 Mar 2025 2024 FY
2022 $628,000 -$831,000 -57% 01 Jan 2022 31 Dec 2022 10-K 17 Mar 2025 2024 FY
2021 $1,459,000 +$804,000 +123% 01 Jan 2021 31 Dec 2021 10-K 14 Mar 2024 2023 FY
2020 $655,000 +$28,000 +4.5% 01 Jan 2020 31 Dec 2020 10-K 27 Feb 2023 2022 FY
2019 $627,000 -$59,000 -8.6% 01 Jan 2019 31 Dec 2019 10-K 31 Mar 2022 2021 FY
2018 $686,000 -$285,000 -29% 01 Jan 2018 31 Dec 2018 10-K 30 Mar 2021 2020 FY
2017 $971,000 +$122,000 +14% 01 Jan 2017 31 Dec 2017 10-K 12 Mar 2020 2019 FY
2016 $849,000 +$385,000 +83% 01 Jan 2016 31 Dec 2016 10-K 18 Mar 2019 2018 FY
2015 $464,000 -$321,000 -41% 01 Jan 2015 31 Dec 2015 10-K 06 Mar 2018 2017 FY
2014 $785,000 -$1,105,000 -58% 01 Jan 2014 31 Dec 2014 10-K 16 Mar 2017 2016 FY
2013 $1,890,000 -$178,000 -8.6% 01 Jan 2013 31 Dec 2013 10-K 08 Mar 2016 2015 FY
2012 $2,068,000 -$3,637,000 -64% 01 Jan 2012 31 Dec 2012 10-K 12 Mar 2015 2014 FY
2011 $5,705,000 -$2,150,000 -27% 01 Jan 2011 31 Dec 2011 10-K 13 Mar 2014 2013 FY
2010 $7,855,000 01 Jan 2010 31 Dec 2010 10-K 28 Feb 2013 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.